Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
26 November 2015: Meta-Analysis
Association Between Single-Nucleotide Polymorphism (SNP) in miR-146a, miR-196a2, and miR-499 and Risk of Ischemic Stroke: A Meta-Analysis
Jie Zhu ABCDE , Hongsheng Yue BCDE , ChuanWu Qiao ABEF , Yun Li ABCDEFG
DOI: 10.12659/MSM.895233
Med Sci Monit 2015; 21:3658-3663
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
Abstract
BACKGROUND: The association between 3 well known SNPs – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – in pre-miRNA sequences and ischemic stroke (IS) are still conflicting and inconclusive. This meta-analysis aimed to pool previous studies get a more precise assessment of the association between these 3 SNPs and the risk of IS.
MATERIAL AND METHODS: Relevant studies were searched in online databases. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) using Review Manager (version 5.3).
RESULTS: Rs2910164 C allele was associated with lower IS risk. But this trend was only observed in Koreans under the allele model (OR=0.81, 95% CI=0.68-0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007). Rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese, but not in Koreans.
CONCLUSIONS: Although the 3 SNPs might be associated with IS, the association varied significantly in different countries.
Keywords: Case-Control Studies, Asian Continental Ancestry Group, Genetic Predisposition to Disease, MicroRNAs - genetics, Polymorphism, Single Nucleotide, Stroke - genetics
Background
Stroke causes about 11% of all death across the world and is the most common cause of adult-acquired disability [1]. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) constitute about 80–85% and 15–20% of all stroke cases, respectively [1]. IS is a highly complex disease caused by multiple genetic and environmental risk factors [2]. Several susceptible genes associated with increased risk of IS have been recognized, such as ACE, F5, MTHFR, and APOE [3]. But these findings only revealed a part of the inherited risk of IS. It is necessary to further study the genetic background and disease susceptibility genes to better understand this disease.
MicroRNAs (miRNAs) are a group of small (~22-nucleotide) and conserved endogenous non-coding RNA. They can bind to the 3′-untranslated region (3′-UTR) of target mRNAs, thereby regulating gene expression through translational repression or mRNA degradation [4]. Single-nucleotide polymorphisms (SNPs) were the most frequent variation in the human genome. SNPs or mutations in mature miRNAs may affect the maturation process or target selection, thus influencing the downstream physiological processes [5,6]. Three well-known SNPs in pre-miRNA sequences – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – have been widely studied and were associated with the risk of several diseases [7,8]. In fact, miR-146a is closely related to regulation of tumor necrosis factor-α (TNF-α) [9]. MiR-146a were significantly downregulated in patients with IS in the acute phase but upregulated in the subacute phase [10], exerting a neuroprotective effect through astrocytes [11]. MiR-196a2 can target annexin A1 [12]. MiR-499 can affect the inflammatory reaction through modulating C-reactive protein (CRP) [13]. Therefore, these 3 miRNAs may play important roles in regulating thrombosis or inflammation pathways in the circulation system. Considering the important role of the SNPs in the expression or targeting of the miRNAs, several recent studies tried to explore the influence of the SNPs on IS risk [14–17]. However, the results were conflicting and inconclusive. The present meta-analysis aimed to pool previous studies to get a more precise assessment of the association between the 3 SNPs and the risk of IS.
Material and Methods
SEARCHING STRATEGY:
Relevant studies published before 1 June 2015 were systematically searched by 2 authors independently in the databases, including PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBLM) by using the following searching terms: “ischemic stroke (IS)” and (“single nucleotide polymorphism” or “polymorphism” or “mutation” or “variant” or “SNP”) and (“microRNA” or “miRNA” or “miR”). No language restriction was applied for searching. Reference list of studies included and other relevant meta-analyses or reviews were manually searched to find other potentially qualified studies.
Studies meeting the following criteria were included in this meta-analysis: (1) Case-control design; (2) Studies assessed the association between SNP of miRNAs and the risk of IS; (3) the genotype distribution of the controls agreed with the Hardy-Weinberg equilibrium (HWE); (4) Detailed data of genotype frequency could be extracted from original studies. Repeat studies and studies without detailed data were excluded.
DATA EXTRACTION:
Two authors independently extracted data from the original studies. The information extracted included surname of the first author, year of publication, country, ethnicity, disease, numbers of subjects, age, sex, source of controls, genotyping methods, genotype frequency of case and control, and p value of Hardy-Weinberg equilibrium (HWE) in controls. Disagreement was resolved by referring to original studies in group discussion.
QUALITY ASSESSMENT OF STUDIES INCLUDED:
The quality of included studies was assessed using the modified Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) quality score system. This system has 40 assessment items to assess a trial’s quality by giving scores from 0 to 40. Based on the scoring, the quality is defined as low quality (0–19), moderate quality (20–29), or high quality (30–40).
STATISTICAL ANALYSIS:
Cochrane Review Manager (version 5.3, Cochrane Collaboration, Copenhagen, Denmark) was used for data integration and analysis. The χ2 test was used to evaluate the HWE of the control group. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) under 5 genetic models, including allele model, homozygote model, heterozygote model, dominant model, and recessive model. Statistical heterogeneity among studies was assessed using the chi square-based Q test and I2 [12]. χ2 tests p<0.1 or I2 >50% indicates significant heterogeneity [12]. If there was significant heterogeneity among the studies, the random-effects model (the DerSimonian and Laird method) was used to make estimates, otherwise the fixed-effects model (Mantel-Haenszel method) was used. Since only 5 original studies were involved, there was no need to assess the publication bias. The statistical significance of the pooled OR was determined by Z test and p<0.05 was considered as a significant difference.
Results
CHARACTERISTICS OF STUDIES INCLUDED:
A total of 8 studies were found through searching in the databases. Among them, 2 were excluded for irrelevance and 1 meta-analysis was excluded. Finally, 5 studies meeting the criteria were included [14–18], among which 2254 cases and 2506 controls were included. The flow chart summarizing the search process is shown in Figure 1 and the basic information of the included studies is given in Table 1. Among the 5 studies, 5 assessed the association between miR-146a (rs2910164) and IS risks, 4 assessed miR-196a2 (rs11614913), and 3 assessed miR-499 (rs3746444). The genotype distribution of rs2910164, rs11614913, and rs3746444 is presented in Table 2. All of the studies had genotype distribution in controls in agreement with Hardy-Weinberg equilibrium (HWE) expectation.
RESULTS OF META-ANALYSIS:
The results of meta-analysis for the association between the 3 SNPs (rs2910164, rs11614913, and rs3746444) and the IS risks are shown in Table 3.
MIR-146A RS2910164 C/G AND THE RISK OF IS:
There was no significant association between this SNP and the IS risk under all genetic models. When performing a subgroup analysis by country, a similar trend was observed in the Chinese population. However, significant associations were observed in the Korean population under the allele model (OR=0.81, 95% CI=0.68–0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007) (Table 3), suggesting there might be some protective effect of the C allele in Koreans.
MIR-196A2 RS11614913 T/C AND THE RISK OF IS:
For rs11614913, a significant association between T allele and increased IS risk was observed under the dominant model (OR=1.35, 95% CI=1.15–1.59, p=0.0003), but not under other models. Subgroup analysis showed this association was only significant in Chinese (OR=1.45, 95% CI=1.19–1.78, p=0.0003), but not in Koreans (Table 3).
MIR-499 RS3746444 A/G AND THE RISK OF IS:
For rs3746444, there was no significant association between this SNP and the IS risk under all genetic models, but subgroup analysis showed homozygote AA was associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) (Table 3) in Chinese.
Discussion
In this study, we found that, although the 3 SNPs might be associated with IS, the association varied significantly in different countries. rs2910164 C allele was associated with lower IS risk, but this trend was only observed in Koreans under the allele model, dominant model, recessive model, and homozygous model. rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese. These results suggest that the effect of the SNPs might be significantly related to genetic background of a population.
Some recent studies found some miRNAs are dysregulated in IS. For example, miR-497 can directly bind to the 3′UTR of B-cell lymphoma 2 (Bcl-2) and Bcl-w mRNAs, whose proteins play an important role in attenuating stroke-induced apoptotic cell death [19]. MiR-29b expression was significantly increased in rat brains by focal ischemia. It can also directly bind to the Bcl-2 mRNA and thereby promote neuronal cell death [20]. The miR-146a/rs2910164, miR-196a2/rs11614913, and miR-499/rs3746444 were all in the 3p strand of mature miRNA regions. The G allele of rs2910164 and T allele of rs11614913 are associated with decreased mature miRNA levels [21,22]. This might help to explain why these 2 alleles were associated with increased risk of IS in Koreans and Chinese. In fact, miR-146a can regulate the expression of TNF-α and also inhibit the pro-inflammatory MAP kinase pathway and NF-κB pathway [23], which are closely related to occurrence of IS. A recent study found stroke acutely activates the Toll-like receptor (TLR) signaling pathway in cerebral vasculature. Upregulation of miR-146a contributes to neuroprotection, partly through inactivation of the TLR signaling pathway [24]. MiR-196a2 can regulate annexin A1, which has significant repressing effects on both neutrophil and monocyte migration and adhesion in atherosclerosis. Annexin A1, as an important endogenous anti-inflammatory mediator, can also repress the expression and activation of inflammatory enzymes, such as inducible cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), and phospholipase A2 [25]. Therefore, through regulating annexin A1, miR-196a2 might exert some effect in IS. MiR-499 can regulate CRP, a protein closely related to cerebral ischemia. In addition, mi-499 can also regulate cell apoptosis and cell death in anoxia and ischemia conditions by targeting calcineurin and dynamin-related protein-1 [26]. Since rs3746444 A/G mutation might affect binding of targeting mRNAs and maturation of pre-miRNA, it is possible that this SNP might significantly affect downstream biological functions.
This study also has several limitations. Firstly, due to the limited number of original studies, the number of patients included was relatively small. After a comprehensive literature search, only 5 eligible studies were included. Secondly, the information on clinicopathological characteristics or disease subtypes was poorly provided in original studies, making it difficult to perform more subgroup meta-analysis. Thirdly, IS is a disease influenced by both genetic and environmental factors. The gene-gene and gene-environment interactions may significantly affect function of a single SNP. Therefore, the exact effect of the SNPs may vary in different populations with different genetic backgrounds. In addition, a SNP might be in linkage disequilibrium with other genetic variations of stroke susceptibility genes, which may present stronger effect when considered together with other variations. These hypotheses need to be tested in future studies.
Conclusions
The current meta-analysis suggests that rs2910164 C allele might be associated with lower IS risk in Koreans. rs11614913 T allele might be associated with higher IS risk under the dominant model, while rs3746444 A allele might be associated with decreased IS risk under the homozygous model in Chinese. However, these findings should be further verified in studies with large sample sizes.
References
1. Norrving B, Kissela B, The global burden of stroke and need for a continuum of care: Neurology, 2013; 80; S5-12, pmid: 23319486
2. Domingues-Montanari S, Mendioroz M, del Rio-Espinola A, Genetics of stroke: a review of recent advances: Expert Rev Mol Diagn, 2008; 8(4); 495-513, pmid: 18598230
3. Bersano A, Ballabio E, Bresolin N, Candelise L, Genetic polymorphisms for the study of multifactorial stroke: Hum Mutat, 2008; 29(6); 776-95, pmid: 18421701
4. Ambros V, The functions of animal microRNAs: Nature, 2004; 431; 350-55, pmid: 15372042
5. Jazdzewski K, Murray EL, Franssila K, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma: Proc Natl Acad Sci USA, 2008; 105(20); 7269-74, pmid: 18474871
6. Yang R, Schlehe B, Hemminki K, A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk: Breast Cancer Res Treat, 2010; 121(3); 693-702, pmid: 19921425
7. Ryan BM, Robles AI, Harris CC, Genetic variation in microRNA networks: the implications for cancer research: Nat Rev Cancer, 2010; 10(6); 389-402, pmid: 20495573
8. Park YS, Jeon YJ, Lee BE, Association of the miR-146aC>G, miR-196a2C>T, and miR-499A>G polymorphisms with moyamoya disease in the Korean population: Neurosci Lett, 2012; 521(1); 71-75, pmid: 22659075
9. El Gazzar M, Church A, Liu T, McCall CE, MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming: J Leukoc Biol, 2011; 90(3); 509-19, pmid: 21562054
10. Li SH, Su SY, Liu JL, Differential regulation of microRNAs in patients with ischemic stroke: Curr Neurovasc Res, 2015; 12(3); 214-21, pmid: 26044809
11. Ouyang YB, Xu L, Yue S, Neuroprotection by astrocytes in brain ischemia: importance of microRNAs: Neurosci Lett, 2014; 565; 53-58, pmid: 24269978
12. Luthra R, Singh RR, Luthra MG, MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers: Oncogene, 2008; 27(52); 6667-78, pmid: 18663355
13. Yang B, Chen J, Li Y, Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population: Hum Immunol, 2012; 73(1); 101-6, pmid: 22019503
14. Jeon YJ, Kim OJ, Kim SY, Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk: Arterioscler Thromb Vasc Biol, 2013; 33(2); 420-30, pmid: 23202363
15. Zhu R, Liu X, He Z, Li Q, miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population: Neurochem Res, 2014; 39(9); 1709-16, pmid: 24952884
16. Huang S, Zhou S, Zhang Y, Cheng, Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese population: PLoS One, 2015; 10(2); e0117007, pmid: 25658319
17. Liu Y, Ma Y, Zhang B, Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population: J Mol Neurosci, 2014; 52(4); 473-80, pmid: 24178064
18. Sun J, Association of miR-146a and EPHX2 polymorphisms with risk of ischemic stroke in Changsha Han population and the mechanisms: Master Graduation Thesis, 2011, the Central South University
19. Yadav S, Pandey A, Shukla A, miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2: J Biol Chem, 2011; 286(43); 37347-57, pmid: 21878650
20. Shi G, Liu Y, Liu T, Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury: Exp Brain Res, 2012; 216(2); 225-30, pmid: 22094713
21. Shen J, Ambrosone CB, DiCioccio RA, A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis: Carcinogenesis, 2008; 29(10); 1963-66, pmid: 18660546
22. Hoffman AE, Zheng T, Yi C, microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis: Cancer Res, 2009; 69(14); 5970-77, pmid: 19567675
23. Cheng HS, Sivachandran N, Lau A, MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways: EMBO Mol Med, 2013; 5(7); 949-66, pmid: 23733368
24. Zhang L, Chopp M, Liu X, Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway: Arterioscler Thromb Vasc Biol, 2012; 32(8); 1856-64, pmid: 22723435
25. Perretti M, D’Acquisto F, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation: Nat Rev Immunol, 2009; 9(1); 62-70, pmid: 19104500
26. Wang JX, Jiao JQ, Li Q, miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1: Nat Med, 2011; 17(1); 71-78, pmid: 21186368
In Press
Database Analysis
Neutrophil-to-Lymphocyte Ratio as a Marker for Postoperative Stress in Robot-Assisted Total Knee ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.947906
Clinical Research
Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal PregnanciesMed Sci Monit In Press; DOI: 10.12659/MSM.948358
Clinical Research
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Scle...Med Sci Monit In Press; DOI: 10.12659/MSM.948757
Clinical Research
Cochlear Implantation Benefits for Patients with Trauma-Induced Bilateral Hearing Loss: A Retrospective Ana...Med Sci Monit In Press; DOI: 10.12659/MSM.948554
Most Viewed Current Articles
17 Jan 2024 : Review article 10,151,936
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,515
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 33,887
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 28,286
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2025
International Scientific
Infromation, Inc.
All rights reserved.
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
Abstract
BACKGROUND: The association between 3 well known SNPs – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – in pre-miRNA sequences and ischemic stroke (IS) are still conflicting and inconclusive. This meta-analysis aimed to pool previous studies get a more precise assessment of the association between these 3 SNPs and the risk of IS.
MATERIAL AND METHODS: Relevant studies were searched in online databases. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) using Review Manager (version 5.3).
RESULTS: Rs2910164 C allele was associated with lower IS risk. But this trend was only observed in Koreans under the allele model (OR=0.81, 95% CI=0.68-0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007). Rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese, but not in Koreans.
CONCLUSIONS: Although the 3 SNPs might be associated with IS, the association varied significantly in different countries.
Keywords: Case-Control Studies, Asian Continental Ancestry Group, Genetic Predisposition to Disease, MicroRNAs - genetics, Polymorphism, Single Nucleotide, Stroke - genetics
Background
Stroke causes about 11% of all death across the world and is the most common cause of adult-acquired disability [1]. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) constitute about 80–85% and 15–20% of all stroke cases, respectively [1]. IS is a highly complex disease caused by multiple genetic and environmental risk factors [2]. Several susceptible genes associated with increased risk of IS have been recognized, such as ACE, F5, MTHFR, and APOE [3]. But these findings only revealed a part of the inherited risk of IS. It is necessary to further study the genetic background and disease susceptibility genes to better understand this disease.
MicroRNAs (miRNAs) are a group of small (~22-nucleotide) and conserved endogenous non-coding RNA. They can bind to the 3′-untranslated region (3′-UTR) of target mRNAs, thereby regulating gene expression through translational repression or mRNA degradation [4]. Single-nucleotide polymorphisms (SNPs) were the most frequent variation in the human genome. SNPs or mutations in mature miRNAs may affect the maturation process or target selection, thus influencing the downstream physiological processes [5,6]. Three well-known SNPs in pre-miRNA sequences – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – have been widely studied and were associated with the risk of several diseases [7,8]. In fact, miR-146a is closely related to regulation of tumor necrosis factor-α (TNF-α) [9]. MiR-146a were significantly downregulated in patients with IS in the acute phase but upregulated in the subacute phase [10], exerting a neuroprotective effect through astrocytes [11]. MiR-196a2 can target annexin A1 [12]. MiR-499 can affect the inflammatory reaction through modulating C-reactive protein (CRP) [13]. Therefore, these 3 miRNAs may play important roles in regulating thrombosis or inflammation pathways in the circulation system. Considering the important role of the SNPs in the expression or targeting of the miRNAs, several recent studies tried to explore the influence of the SNPs on IS risk [14–17]. However, the results were conflicting and inconclusive. The present meta-analysis aimed to pool previous studies to get a more precise assessment of the association between the 3 SNPs and the risk of IS.
Material and Methods
SEARCHING STRATEGY:
Relevant studies published before 1 June 2015 were systematically searched by 2 authors independently in the databases, including PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBLM) by using the following searching terms: “ischemic stroke (IS)” and (“single nucleotide polymorphism” or “polymorphism” or “mutation” or “variant” or “SNP”) and (“microRNA” or “miRNA” or “miR”). No language restriction was applied for searching. Reference list of studies included and other relevant meta-analyses or reviews were manually searched to find other potentially qualified studies.
Studies meeting the following criteria were included in this meta-analysis: (1) Case-control design; (2) Studies assessed the association between SNP of miRNAs and the risk of IS; (3) the genotype distribution of the controls agreed with the Hardy-Weinberg equilibrium (HWE); (4) Detailed data of genotype frequency could be extracted from original studies. Repeat studies and studies without detailed data were excluded.
DATA EXTRACTION:
Two authors independently extracted data from the original studies. The information extracted included surname of the first author, year of publication, country, ethnicity, disease, numbers of subjects, age, sex, source of controls, genotyping methods, genotype frequency of case and control, and p value of Hardy-Weinberg equilibrium (HWE) in controls. Disagreement was resolved by referring to original studies in group discussion.
QUALITY ASSESSMENT OF STUDIES INCLUDED:
The quality of included studies was assessed using the modified Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) quality score system. This system has 40 assessment items to assess a trial’s quality by giving scores from 0 to 40. Based on the scoring, the quality is defined as low quality (0–19), moderate quality (20–29), or high quality (30–40).
STATISTICAL ANALYSIS:
Cochrane Review Manager (version 5.3, Cochrane Collaboration, Copenhagen, Denmark) was used for data integration and analysis. The χ2 test was used to evaluate the HWE of the control group. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) under 5 genetic models, including allele model, homozygote model, heterozygote model, dominant model, and recessive model. Statistical heterogeneity among studies was assessed using the chi square-based Q test and I2 [12]. χ2 tests p<0.1 or I2 >50% indicates significant heterogeneity [12]. If there was significant heterogeneity among the studies, the random-effects model (the DerSimonian and Laird method) was used to make estimates, otherwise the fixed-effects model (Mantel-Haenszel method) was used. Since only 5 original studies were involved, there was no need to assess the publication bias. The statistical significance of the pooled OR was determined by Z test and p<0.05 was considered as a significant difference.
Results
CHARACTERISTICS OF STUDIES INCLUDED:
A total of 8 studies were found through searching in the databases. Among them, 2 were excluded for irrelevance and 1 meta-analysis was excluded. Finally, 5 studies meeting the criteria were included [14–18], among which 2254 cases and 2506 controls were included. The flow chart summarizing the search process is shown in Figure 1 and the basic information of the included studies is given in Table 1. Among the 5 studies, 5 assessed the association between miR-146a (rs2910164) and IS risks, 4 assessed miR-196a2 (rs11614913), and 3 assessed miR-499 (rs3746444). The genotype distribution of rs2910164, rs11614913, and rs3746444 is presented in Table 2. All of the studies had genotype distribution in controls in agreement with Hardy-Weinberg equilibrium (HWE) expectation.
RESULTS OF META-ANALYSIS:
The results of meta-analysis for the association between the 3 SNPs (rs2910164, rs11614913, and rs3746444) and the IS risks are shown in Table 3.
MIR-146A RS2910164 C/G AND THE RISK OF IS:
There was no significant association between this SNP and the IS risk under all genetic models. When performing a subgroup analysis by country, a similar trend was observed in the Chinese population. However, significant associations were observed in the Korean population under the allele model (OR=0.81, 95% CI=0.68–0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007) (Table 3), suggesting there might be some protective effect of the C allele in Koreans.
MIR-196A2 RS11614913 T/C AND THE RISK OF IS:
For rs11614913, a significant association between T allele and increased IS risk was observed under the dominant model (OR=1.35, 95% CI=1.15–1.59, p=0.0003), but not under other models. Subgroup analysis showed this association was only significant in Chinese (OR=1.45, 95% CI=1.19–1.78, p=0.0003), but not in Koreans (Table 3).
MIR-499 RS3746444 A/G AND THE RISK OF IS:
For rs3746444, there was no significant association between this SNP and the IS risk under all genetic models, but subgroup analysis showed homozygote AA was associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) (Table 3) in Chinese.
Discussion
In this study, we found that, although the 3 SNPs might be associated with IS, the association varied significantly in different countries. rs2910164 C allele was associated with lower IS risk, but this trend was only observed in Koreans under the allele model, dominant model, recessive model, and homozygous model. rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese. These results suggest that the effect of the SNPs might be significantly related to genetic background of a population.
Some recent studies found some miRNAs are dysregulated in IS. For example, miR-497 can directly bind to the 3′UTR of B-cell lymphoma 2 (Bcl-2) and Bcl-w mRNAs, whose proteins play an important role in attenuating stroke-induced apoptotic cell death [19]. MiR-29b expression was significantly increased in rat brains by focal ischemia. It can also directly bind to the Bcl-2 mRNA and thereby promote neuronal cell death [20]. The miR-146a/rs2910164, miR-196a2/rs11614913, and miR-499/rs3746444 were all in the 3p strand of mature miRNA regions. The G allele of rs2910164 and T allele of rs11614913 are associated with decreased mature miRNA levels [21,22]. This might help to explain why these 2 alleles were associated with increased risk of IS in Koreans and Chinese. In fact, miR-146a can regulate the expression of TNF-α and also inhibit the pro-inflammatory MAP kinase pathway and NF-κB pathway [23], which are closely related to occurrence of IS. A recent study found stroke acutely activates the Toll-like receptor (TLR) signaling pathway in cerebral vasculature. Upregulation of miR-146a contributes to neuroprotection, partly through inactivation of the TLR signaling pathway [24]. MiR-196a2 can regulate annexin A1, which has significant repressing effects on both neutrophil and monocyte migration and adhesion in atherosclerosis. Annexin A1, as an important endogenous anti-inflammatory mediator, can also repress the expression and activation of inflammatory enzymes, such as inducible cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), and phospholipase A2 [25]. Therefore, through regulating annexin A1, miR-196a2 might exert some effect in IS. MiR-499 can regulate CRP, a protein closely related to cerebral ischemia. In addition, mi-499 can also regulate cell apoptosis and cell death in anoxia and ischemia conditions by targeting calcineurin and dynamin-related protein-1 [26]. Since rs3746444 A/G mutation might affect binding of targeting mRNAs and maturation of pre-miRNA, it is possible that this SNP might significantly affect downstream biological functions.
This study also has several limitations. Firstly, due to the limited number of original studies, the number of patients included was relatively small. After a comprehensive literature search, only 5 eligible studies were included. Secondly, the information on clinicopathological characteristics or disease subtypes was poorly provided in original studies, making it difficult to perform more subgroup meta-analysis. Thirdly, IS is a disease influenced by both genetic and environmental factors. The gene-gene and gene-environment interactions may significantly affect function of a single SNP. Therefore, the exact effect of the SNPs may vary in different populations with different genetic backgrounds. In addition, a SNP might be in linkage disequilibrium with other genetic variations of stroke susceptibility genes, which may present stronger effect when considered together with other variations. These hypotheses need to be tested in future studies.
Conclusions
The current meta-analysis suggests that rs2910164 C allele might be associated with lower IS risk in Koreans. rs11614913 T allele might be associated with higher IS risk under the dominant model, while rs3746444 A allele might be associated with decreased IS risk under the homozygous model in Chinese. However, these findings should be further verified in studies with large sample sizes.
References
1. Norrving B, Kissela B, The global burden of stroke and need for a continuum of care: Neurology, 2013; 80; S5-12, pmid: 23319486
2. Domingues-Montanari S, Mendioroz M, del Rio-Espinola A, Genetics of stroke: a review of recent advances: Expert Rev Mol Diagn, 2008; 8(4); 495-513, pmid: 18598230
3. Bersano A, Ballabio E, Bresolin N, Candelise L, Genetic polymorphisms for the study of multifactorial stroke: Hum Mutat, 2008; 29(6); 776-95, pmid: 18421701
4. Ambros V, The functions of animal microRNAs: Nature, 2004; 431; 350-55, pmid: 15372042
5. Jazdzewski K, Murray EL, Franssila K, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma: Proc Natl Acad Sci USA, 2008; 105(20); 7269-74, pmid: 18474871
6. Yang R, Schlehe B, Hemminki K, A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk: Breast Cancer Res Treat, 2010; 121(3); 693-702, pmid: 19921425
7. Ryan BM, Robles AI, Harris CC, Genetic variation in microRNA networks: the implications for cancer research: Nat Rev Cancer, 2010; 10(6); 389-402, pmid: 20495573
8. Park YS, Jeon YJ, Lee BE, Association of the miR-146aC>G, miR-196a2C>T, and miR-499A>G polymorphisms with moyamoya disease in the Korean population: Neurosci Lett, 2012; 521(1); 71-75, pmid: 22659075
9. El Gazzar M, Church A, Liu T, McCall CE, MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming: J Leukoc Biol, 2011; 90(3); 509-19, pmid: 21562054
10. Li SH, Su SY, Liu JL, Differential regulation of microRNAs in patients with ischemic stroke: Curr Neurovasc Res, 2015; 12(3); 214-21, pmid: 26044809
11. Ouyang YB, Xu L, Yue S, Neuroprotection by astrocytes in brain ischemia: importance of microRNAs: Neurosci Lett, 2014; 565; 53-58, pmid: 24269978
12. Luthra R, Singh RR, Luthra MG, MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers: Oncogene, 2008; 27(52); 6667-78, pmid: 18663355
13. Yang B, Chen J, Li Y, Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population: Hum Immunol, 2012; 73(1); 101-6, pmid: 22019503
14. Jeon YJ, Kim OJ, Kim SY, Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk: Arterioscler Thromb Vasc Biol, 2013; 33(2); 420-30, pmid: 23202363
15. Zhu R, Liu X, He Z, Li Q, miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population: Neurochem Res, 2014; 39(9); 1709-16, pmid: 24952884
16. Huang S, Zhou S, Zhang Y, Cheng, Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese population: PLoS One, 2015; 10(2); e0117007, pmid: 25658319
17. Liu Y, Ma Y, Zhang B, Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population: J Mol Neurosci, 2014; 52(4); 473-80, pmid: 24178064
18. Sun J, Association of miR-146a and EPHX2 polymorphisms with risk of ischemic stroke in Changsha Han population and the mechanisms: Master Graduation Thesis, 2011, the Central South University
19. Yadav S, Pandey A, Shukla A, miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2: J Biol Chem, 2011; 286(43); 37347-57, pmid: 21878650
20. Shi G, Liu Y, Liu T, Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury: Exp Brain Res, 2012; 216(2); 225-30, pmid: 22094713
21. Shen J, Ambrosone CB, DiCioccio RA, A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis: Carcinogenesis, 2008; 29(10); 1963-66, pmid: 18660546
22. Hoffman AE, Zheng T, Yi C, microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis: Cancer Res, 2009; 69(14); 5970-77, pmid: 19567675
23. Cheng HS, Sivachandran N, Lau A, MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways: EMBO Mol Med, 2013; 5(7); 949-66, pmid: 23733368
24. Zhang L, Chopp M, Liu X, Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway: Arterioscler Thromb Vasc Biol, 2012; 32(8); 1856-64, pmid: 22723435
25. Perretti M, D’Acquisto F, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation: Nat Rev Immunol, 2009; 9(1); 62-70, pmid: 19104500
26. Wang JX, Jiao JQ, Li Q, miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1: Nat Med, 2011; 17(1); 71-78, pmid: 21186368
In Press
Database Analysis
Neutrophil-to-Lymphocyte Ratio as a Marker for Postoperative Stress in Robot-Assisted Total Knee ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.947906
Clinical Research
Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal PregnanciesMed Sci Monit In Press; DOI: 10.12659/MSM.948358
Clinical Research
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Scle...Med Sci Monit In Press; DOI: 10.12659/MSM.948757
Clinical Research
Cochlear Implantation Benefits for Patients with Trauma-Induced Bilateral Hearing Loss: A Retrospective Ana...Med Sci Monit In Press; DOI: 10.12659/MSM.948554
Most Viewed Current Articles
17 Jan 2024 : Review article 10,151,936
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,515
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 33,887
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 28,286
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2025
International Scientific
Infromation, Inc.
All rights reserved.
In Press
Database Analysis
Neutrophil-to-Lymphocyte Ratio as a Marker for Postoperative Stress in Robot-Assisted Total Knee ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.947906
Clinical Research
Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal PregnanciesMed Sci Monit In Press; DOI: 10.12659/MSM.948358
Clinical Research
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Scle...Med Sci Monit In Press; DOI: 10.12659/MSM.948757
Clinical Research
Cochlear Implantation Benefits for Patients with Trauma-Induced Bilateral Hearing Loss: A Retrospective Ana...Med Sci Monit In Press; DOI: 10.12659/MSM.948554
Most Viewed Current Articles
17 Jan 2024 : Review article 10,151,936
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,515
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 33,887
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 28,286
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2025
International Scientific
Infromation, Inc.
All rights reserved.
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
26 November 2015: Meta-Analysis
Association Between Single-Nucleotide Polymorphism (SNP) in miR-146a, miR-196a2, and miR-499 and Risk of Ischemic Stroke: A Meta-Analysis
Jie Zhu ABCDE , Hongsheng Yue BCDE , ChuanWu Qiao ABEF , Yun Li ABCDEFG
DOI: 10.12659/MSM.895233
Med Sci Monit 2015; 21:3658-3663
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
Abstract
BACKGROUND: The association between 3 well known SNPs – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – in pre-miRNA sequences and ischemic stroke (IS) are still conflicting and inconclusive. This meta-analysis aimed to pool previous studies get a more precise assessment of the association between these 3 SNPs and the risk of IS.
MATERIAL AND METHODS: Relevant studies were searched in online databases. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) using Review Manager (version 5.3).
RESULTS: Rs2910164 C allele was associated with lower IS risk. But this trend was only observed in Koreans under the allele model (OR=0.81, 95% CI=0.68-0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007). Rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese, but not in Koreans.
CONCLUSIONS: Although the 3 SNPs might be associated with IS, the association varied significantly in different countries.
Keywords: Case-Control Studies, Asian Continental Ancestry Group, Genetic Predisposition to Disease, MicroRNAs - genetics, Polymorphism, Single Nucleotide, Stroke - genetics
Background
Stroke causes about 11% of all death across the world and is the most common cause of adult-acquired disability [1]. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) constitute about 80–85% and 15–20% of all stroke cases, respectively [1]. IS is a highly complex disease caused by multiple genetic and environmental risk factors [2]. Several susceptible genes associated with increased risk of IS have been recognized, such as ACE, F5, MTHFR, and APOE [3]. But these findings only revealed a part of the inherited risk of IS. It is necessary to further study the genetic background and disease susceptibility genes to better understand this disease.
MicroRNAs (miRNAs) are a group of small (~22-nucleotide) and conserved endogenous non-coding RNA. They can bind to the 3′-untranslated region (3′-UTR) of target mRNAs, thereby regulating gene expression through translational repression or mRNA degradation [4]. Single-nucleotide polymorphisms (SNPs) were the most frequent variation in the human genome. SNPs or mutations in mature miRNAs may affect the maturation process or target selection, thus influencing the downstream physiological processes [5,6]. Three well-known SNPs in pre-miRNA sequences – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – have been widely studied and were associated with the risk of several diseases [7,8]. In fact, miR-146a is closely related to regulation of tumor necrosis factor-α (TNF-α) [9]. MiR-146a were significantly downregulated in patients with IS in the acute phase but upregulated in the subacute phase [10], exerting a neuroprotective effect through astrocytes [11]. MiR-196a2 can target annexin A1 [12]. MiR-499 can affect the inflammatory reaction through modulating C-reactive protein (CRP) [13]. Therefore, these 3 miRNAs may play important roles in regulating thrombosis or inflammation pathways in the circulation system. Considering the important role of the SNPs in the expression or targeting of the miRNAs, several recent studies tried to explore the influence of the SNPs on IS risk [14–17]. However, the results were conflicting and inconclusive. The present meta-analysis aimed to pool previous studies to get a more precise assessment of the association between the 3 SNPs and the risk of IS.
Material and Methods
SEARCHING STRATEGY:
Relevant studies published before 1 June 2015 were systematically searched by 2 authors independently in the databases, including PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBLM) by using the following searching terms: “ischemic stroke (IS)” and (“single nucleotide polymorphism” or “polymorphism” or “mutation” or “variant” or “SNP”) and (“microRNA” or “miRNA” or “miR”). No language restriction was applied for searching. Reference list of studies included and other relevant meta-analyses or reviews were manually searched to find other potentially qualified studies.
Studies meeting the following criteria were included in this meta-analysis: (1) Case-control design; (2) Studies assessed the association between SNP of miRNAs and the risk of IS; (3) the genotype distribution of the controls agreed with the Hardy-Weinberg equilibrium (HWE); (4) Detailed data of genotype frequency could be extracted from original studies. Repeat studies and studies without detailed data were excluded.
DATA EXTRACTION:
Two authors independently extracted data from the original studies. The information extracted included surname of the first author, year of publication, country, ethnicity, disease, numbers of subjects, age, sex, source of controls, genotyping methods, genotype frequency of case and control, and p value of Hardy-Weinberg equilibrium (HWE) in controls. Disagreement was resolved by referring to original studies in group discussion.
QUALITY ASSESSMENT OF STUDIES INCLUDED:
The quality of included studies was assessed using the modified Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) quality score system. This system has 40 assessment items to assess a trial’s quality by giving scores from 0 to 40. Based on the scoring, the quality is defined as low quality (0–19), moderate quality (20–29), or high quality (30–40).
STATISTICAL ANALYSIS:
Cochrane Review Manager (version 5.3, Cochrane Collaboration, Copenhagen, Denmark) was used for data integration and analysis. The χ2 test was used to evaluate the HWE of the control group. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) under 5 genetic models, including allele model, homozygote model, heterozygote model, dominant model, and recessive model. Statistical heterogeneity among studies was assessed using the chi square-based Q test and I2 [12]. χ2 tests p<0.1 or I2 >50% indicates significant heterogeneity [12]. If there was significant heterogeneity among the studies, the random-effects model (the DerSimonian and Laird method) was used to make estimates, otherwise the fixed-effects model (Mantel-Haenszel method) was used. Since only 5 original studies were involved, there was no need to assess the publication bias. The statistical significance of the pooled OR was determined by Z test and p<0.05 was considered as a significant difference.
Results
CHARACTERISTICS OF STUDIES INCLUDED:
A total of 8 studies were found through searching in the databases. Among them, 2 were excluded for irrelevance and 1 meta-analysis was excluded. Finally, 5 studies meeting the criteria were included [14–18], among which 2254 cases and 2506 controls were included. The flow chart summarizing the search process is shown in Figure 1 and the basic information of the included studies is given in Table 1. Among the 5 studies, 5 assessed the association between miR-146a (rs2910164) and IS risks, 4 assessed miR-196a2 (rs11614913), and 3 assessed miR-499 (rs3746444). The genotype distribution of rs2910164, rs11614913, and rs3746444 is presented in Table 2. All of the studies had genotype distribution in controls in agreement with Hardy-Weinberg equilibrium (HWE) expectation.
RESULTS OF META-ANALYSIS:
The results of meta-analysis for the association between the 3 SNPs (rs2910164, rs11614913, and rs3746444) and the IS risks are shown in Table 3.
MIR-146A RS2910164 C/G AND THE RISK OF IS:
There was no significant association between this SNP and the IS risk under all genetic models. When performing a subgroup analysis by country, a similar trend was observed in the Chinese population. However, significant associations were observed in the Korean population under the allele model (OR=0.81, 95% CI=0.68–0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007) (Table 3), suggesting there might be some protective effect of the C allele in Koreans.
MIR-196A2 RS11614913 T/C AND THE RISK OF IS:
For rs11614913, a significant association between T allele and increased IS risk was observed under the dominant model (OR=1.35, 95% CI=1.15–1.59, p=0.0003), but not under other models. Subgroup analysis showed this association was only significant in Chinese (OR=1.45, 95% CI=1.19–1.78, p=0.0003), but not in Koreans (Table 3).
MIR-499 RS3746444 A/G AND THE RISK OF IS:
For rs3746444, there was no significant association between this SNP and the IS risk under all genetic models, but subgroup analysis showed homozygote AA was associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) (Table 3) in Chinese.
Discussion
In this study, we found that, although the 3 SNPs might be associated with IS, the association varied significantly in different countries. rs2910164 C allele was associated with lower IS risk, but this trend was only observed in Koreans under the allele model, dominant model, recessive model, and homozygous model. rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese. These results suggest that the effect of the SNPs might be significantly related to genetic background of a population.
Some recent studies found some miRNAs are dysregulated in IS. For example, miR-497 can directly bind to the 3′UTR of B-cell lymphoma 2 (Bcl-2) and Bcl-w mRNAs, whose proteins play an important role in attenuating stroke-induced apoptotic cell death [19]. MiR-29b expression was significantly increased in rat brains by focal ischemia. It can also directly bind to the Bcl-2 mRNA and thereby promote neuronal cell death [20]. The miR-146a/rs2910164, miR-196a2/rs11614913, and miR-499/rs3746444 were all in the 3p strand of mature miRNA regions. The G allele of rs2910164 and T allele of rs11614913 are associated with decreased mature miRNA levels [21,22]. This might help to explain why these 2 alleles were associated with increased risk of IS in Koreans and Chinese. In fact, miR-146a can regulate the expression of TNF-α and also inhibit the pro-inflammatory MAP kinase pathway and NF-κB pathway [23], which are closely related to occurrence of IS. A recent study found stroke acutely activates the Toll-like receptor (TLR) signaling pathway in cerebral vasculature. Upregulation of miR-146a contributes to neuroprotection, partly through inactivation of the TLR signaling pathway [24]. MiR-196a2 can regulate annexin A1, which has significant repressing effects on both neutrophil and monocyte migration and adhesion in atherosclerosis. Annexin A1, as an important endogenous anti-inflammatory mediator, can also repress the expression and activation of inflammatory enzymes, such as inducible cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), and phospholipase A2 [25]. Therefore, through regulating annexin A1, miR-196a2 might exert some effect in IS. MiR-499 can regulate CRP, a protein closely related to cerebral ischemia. In addition, mi-499 can also regulate cell apoptosis and cell death in anoxia and ischemia conditions by targeting calcineurin and dynamin-related protein-1 [26]. Since rs3746444 A/G mutation might affect binding of targeting mRNAs and maturation of pre-miRNA, it is possible that this SNP might significantly affect downstream biological functions.
This study also has several limitations. Firstly, due to the limited number of original studies, the number of patients included was relatively small. After a comprehensive literature search, only 5 eligible studies were included. Secondly, the information on clinicopathological characteristics or disease subtypes was poorly provided in original studies, making it difficult to perform more subgroup meta-analysis. Thirdly, IS is a disease influenced by both genetic and environmental factors. The gene-gene and gene-environment interactions may significantly affect function of a single SNP. Therefore, the exact effect of the SNPs may vary in different populations with different genetic backgrounds. In addition, a SNP might be in linkage disequilibrium with other genetic variations of stroke susceptibility genes, which may present stronger effect when considered together with other variations. These hypotheses need to be tested in future studies.
Conclusions
The current meta-analysis suggests that rs2910164 C allele might be associated with lower IS risk in Koreans. rs11614913 T allele might be associated with higher IS risk under the dominant model, while rs3746444 A allele might be associated with decreased IS risk under the homozygous model in Chinese. However, these findings should be further verified in studies with large sample sizes.
References
1. Norrving B, Kissela B, The global burden of stroke and need for a continuum of care: Neurology, 2013; 80; S5-12, pmid: 23319486
2. Domingues-Montanari S, Mendioroz M, del Rio-Espinola A, Genetics of stroke: a review of recent advances: Expert Rev Mol Diagn, 2008; 8(4); 495-513, pmid: 18598230
3. Bersano A, Ballabio E, Bresolin N, Candelise L, Genetic polymorphisms for the study of multifactorial stroke: Hum Mutat, 2008; 29(6); 776-95, pmid: 18421701
4. Ambros V, The functions of animal microRNAs: Nature, 2004; 431; 350-55, pmid: 15372042
5. Jazdzewski K, Murray EL, Franssila K, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma: Proc Natl Acad Sci USA, 2008; 105(20); 7269-74, pmid: 18474871
6. Yang R, Schlehe B, Hemminki K, A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk: Breast Cancer Res Treat, 2010; 121(3); 693-702, pmid: 19921425
7. Ryan BM, Robles AI, Harris CC, Genetic variation in microRNA networks: the implications for cancer research: Nat Rev Cancer, 2010; 10(6); 389-402, pmid: 20495573
8. Park YS, Jeon YJ, Lee BE, Association of the miR-146aC>G, miR-196a2C>T, and miR-499A>G polymorphisms with moyamoya disease in the Korean population: Neurosci Lett, 2012; 521(1); 71-75, pmid: 22659075
9. El Gazzar M, Church A, Liu T, McCall CE, MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming: J Leukoc Biol, 2011; 90(3); 509-19, pmid: 21562054
10. Li SH, Su SY, Liu JL, Differential regulation of microRNAs in patients with ischemic stroke: Curr Neurovasc Res, 2015; 12(3); 214-21, pmid: 26044809
11. Ouyang YB, Xu L, Yue S, Neuroprotection by astrocytes in brain ischemia: importance of microRNAs: Neurosci Lett, 2014; 565; 53-58, pmid: 24269978
12. Luthra R, Singh RR, Luthra MG, MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers: Oncogene, 2008; 27(52); 6667-78, pmid: 18663355
13. Yang B, Chen J, Li Y, Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population: Hum Immunol, 2012; 73(1); 101-6, pmid: 22019503
14. Jeon YJ, Kim OJ, Kim SY, Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk: Arterioscler Thromb Vasc Biol, 2013; 33(2); 420-30, pmid: 23202363
15. Zhu R, Liu X, He Z, Li Q, miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population: Neurochem Res, 2014; 39(9); 1709-16, pmid: 24952884
16. Huang S, Zhou S, Zhang Y, Cheng, Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese population: PLoS One, 2015; 10(2); e0117007, pmid: 25658319
17. Liu Y, Ma Y, Zhang B, Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population: J Mol Neurosci, 2014; 52(4); 473-80, pmid: 24178064
18. Sun J, Association of miR-146a and EPHX2 polymorphisms with risk of ischemic stroke in Changsha Han population and the mechanisms: Master Graduation Thesis, 2011, the Central South University
19. Yadav S, Pandey A, Shukla A, miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2: J Biol Chem, 2011; 286(43); 37347-57, pmid: 21878650
20. Shi G, Liu Y, Liu T, Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury: Exp Brain Res, 2012; 216(2); 225-30, pmid: 22094713
21. Shen J, Ambrosone CB, DiCioccio RA, A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis: Carcinogenesis, 2008; 29(10); 1963-66, pmid: 18660546
22. Hoffman AE, Zheng T, Yi C, microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis: Cancer Res, 2009; 69(14); 5970-77, pmid: 19567675
23. Cheng HS, Sivachandran N, Lau A, MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways: EMBO Mol Med, 2013; 5(7); 949-66, pmid: 23733368
24. Zhang L, Chopp M, Liu X, Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway: Arterioscler Thromb Vasc Biol, 2012; 32(8); 1856-64, pmid: 22723435
25. Perretti M, D’Acquisto F, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation: Nat Rev Immunol, 2009; 9(1); 62-70, pmid: 19104500
26. Wang JX, Jiao JQ, Li Q, miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1: Nat Med, 2011; 17(1); 71-78, pmid: 21186368
In Press
Database Analysis
Neutrophil-to-Lymphocyte Ratio as a Marker for Postoperative Stress in Robot-Assisted Total Knee ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.947906
Clinical Research
Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal PregnanciesMed Sci Monit In Press; DOI: 10.12659/MSM.948358
Clinical Research
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Scle...Med Sci Monit In Press; DOI: 10.12659/MSM.948757
Clinical Research
Cochlear Implantation Benefits for Patients with Trauma-Induced Bilateral Hearing Loss: A Retrospective Ana...Med Sci Monit In Press; DOI: 10.12659/MSM.948554
Most Viewed Current Articles
17 Jan 2024 : Review article 10,151,936
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,515
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 33,887
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 28,286
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2025
International Scientific
Infromation, Inc.
All rights reserved.
In Press
Database Analysis
Neutrophil-to-Lymphocyte Ratio as a Marker for Postoperative Stress in Robot-Assisted Total Knee ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.947906
Clinical Research
Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal PregnanciesMed Sci Monit In Press; DOI: 10.12659/MSM.948358
Clinical Research
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Scle...Med Sci Monit In Press; DOI: 10.12659/MSM.948757
Clinical Research
Cochlear Implantation Benefits for Patients with Trauma-Induced Bilateral Hearing Loss: A Retrospective Ana...Med Sci Monit In Press; DOI: 10.12659/MSM.948554
Most Viewed Current Articles
17 Jan 2024 : Review article 10,151,936
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,515
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 33,887
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 28,286
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2025
International Scientific
Infromation, Inc.
All rights reserved.
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
Abstract
BACKGROUND: The association between 3 well known SNPs – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – in pre-miRNA sequences and ischemic stroke (IS) are still conflicting and inconclusive. This meta-analysis aimed to pool previous studies get a more precise assessment of the association between these 3 SNPs and the risk of IS.
MATERIAL AND METHODS: Relevant studies were searched in online databases. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) using Review Manager (version 5.3).
RESULTS: Rs2910164 C allele was associated with lower IS risk. But this trend was only observed in Koreans under the allele model (OR=0.81, 95% CI=0.68-0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007). Rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese, but not in Koreans.
CONCLUSIONS: Although the 3 SNPs might be associated with IS, the association varied significantly in different countries.
Keywords: Case-Control Studies, Asian Continental Ancestry Group, Genetic Predisposition to Disease, MicroRNAs - genetics, Polymorphism, Single Nucleotide, Stroke - genetics
Background
Stroke causes about 11% of all death across the world and is the most common cause of adult-acquired disability [1]. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) constitute about 80–85% and 15–20% of all stroke cases, respectively [1]. IS is a highly complex disease caused by multiple genetic and environmental risk factors [2]. Several susceptible genes associated with increased risk of IS have been recognized, such as ACE, F5, MTHFR, and APOE [3]. But these findings only revealed a part of the inherited risk of IS. It is necessary to further study the genetic background and disease susceptibility genes to better understand this disease.
MicroRNAs (miRNAs) are a group of small (~22-nucleotide) and conserved endogenous non-coding RNA. They can bind to the 3′-untranslated region (3′-UTR) of target mRNAs, thereby regulating gene expression through translational repression or mRNA degradation [4]. Single-nucleotide polymorphisms (SNPs) were the most frequent variation in the human genome. SNPs or mutations in mature miRNAs may affect the maturation process or target selection, thus influencing the downstream physiological processes [5,6]. Three well-known SNPs in pre-miRNA sequences – miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) – have been widely studied and were associated with the risk of several diseases [7,8]. In fact, miR-146a is closely related to regulation of tumor necrosis factor-α (TNF-α) [9]. MiR-146a were significantly downregulated in patients with IS in the acute phase but upregulated in the subacute phase [10], exerting a neuroprotective effect through astrocytes [11]. MiR-196a2 can target annexin A1 [12]. MiR-499 can affect the inflammatory reaction through modulating C-reactive protein (CRP) [13]. Therefore, these 3 miRNAs may play important roles in regulating thrombosis or inflammation pathways in the circulation system. Considering the important role of the SNPs in the expression or targeting of the miRNAs, several recent studies tried to explore the influence of the SNPs on IS risk [14–17]. However, the results were conflicting and inconclusive. The present meta-analysis aimed to pool previous studies to get a more precise assessment of the association between the 3 SNPs and the risk of IS.
Material and Methods
SEARCHING STRATEGY:
Relevant studies published before 1 June 2015 were systematically searched by 2 authors independently in the databases, including PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBLM) by using the following searching terms: “ischemic stroke (IS)” and (“single nucleotide polymorphism” or “polymorphism” or “mutation” or “variant” or “SNP”) and (“microRNA” or “miRNA” or “miR”). No language restriction was applied for searching. Reference list of studies included and other relevant meta-analyses or reviews were manually searched to find other potentially qualified studies.
Studies meeting the following criteria were included in this meta-analysis: (1) Case-control design; (2) Studies assessed the association between SNP of miRNAs and the risk of IS; (3) the genotype distribution of the controls agreed with the Hardy-Weinberg equilibrium (HWE); (4) Detailed data of genotype frequency could be extracted from original studies. Repeat studies and studies without detailed data were excluded.
DATA EXTRACTION:
Two authors independently extracted data from the original studies. The information extracted included surname of the first author, year of publication, country, ethnicity, disease, numbers of subjects, age, sex, source of controls, genotyping methods, genotype frequency of case and control, and p value of Hardy-Weinberg equilibrium (HWE) in controls. Disagreement was resolved by referring to original studies in group discussion.
QUALITY ASSESSMENT OF STUDIES INCLUDED:
The quality of included studies was assessed using the modified Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) quality score system. This system has 40 assessment items to assess a trial’s quality by giving scores from 0 to 40. Based on the scoring, the quality is defined as low quality (0–19), moderate quality (20–29), or high quality (30–40).
STATISTICAL ANALYSIS:
Cochrane Review Manager (version 5.3, Cochrane Collaboration, Copenhagen, Denmark) was used for data integration and analysis. The χ2 test was used to evaluate the HWE of the control group. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) under 5 genetic models, including allele model, homozygote model, heterozygote model, dominant model, and recessive model. Statistical heterogeneity among studies was assessed using the chi square-based Q test and I2 [12]. χ2 tests p<0.1 or I2 >50% indicates significant heterogeneity [12]. If there was significant heterogeneity among the studies, the random-effects model (the DerSimonian and Laird method) was used to make estimates, otherwise the fixed-effects model (Mantel-Haenszel method) was used. Since only 5 original studies were involved, there was no need to assess the publication bias. The statistical significance of the pooled OR was determined by Z test and p<0.05 was considered as a significant difference.
Results
CHARACTERISTICS OF STUDIES INCLUDED:
A total of 8 studies were found through searching in the databases. Among them, 2 were excluded for irrelevance and 1 meta-analysis was excluded. Finally, 5 studies meeting the criteria were included [14–18], among which 2254 cases and 2506 controls were included. The flow chart summarizing the search process is shown in Figure 1 and the basic information of the included studies is given in Table 1. Among the 5 studies, 5 assessed the association between miR-146a (rs2910164) and IS risks, 4 assessed miR-196a2 (rs11614913), and 3 assessed miR-499 (rs3746444). The genotype distribution of rs2910164, rs11614913, and rs3746444 is presented in Table 2. All of the studies had genotype distribution in controls in agreement with Hardy-Weinberg equilibrium (HWE) expectation.
RESULTS OF META-ANALYSIS:
The results of meta-analysis for the association between the 3 SNPs (rs2910164, rs11614913, and rs3746444) and the IS risks are shown in Table 3.
MIR-146A RS2910164 C/G AND THE RISK OF IS:
There was no significant association between this SNP and the IS risk under all genetic models. When performing a subgroup analysis by country, a similar trend was observed in the Chinese population. However, significant associations were observed in the Korean population under the allele model (OR=0.81, 95% CI=0.68–0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50–0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63–1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45–0.88, p=0.007) (Table 3), suggesting there might be some protective effect of the C allele in Koreans.
MIR-196A2 RS11614913 T/C AND THE RISK OF IS:
For rs11614913, a significant association between T allele and increased IS risk was observed under the dominant model (OR=1.35, 95% CI=1.15–1.59, p=0.0003), but not under other models. Subgroup analysis showed this association was only significant in Chinese (OR=1.45, 95% CI=1.19–1.78, p=0.0003), but not in Koreans (Table 3).
MIR-499 RS3746444 A/G AND THE RISK OF IS:
For rs3746444, there was no significant association between this SNP and the IS risk under all genetic models, but subgroup analysis showed homozygote AA was associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) (Table 3) in Chinese.
Discussion
In this study, we found that, although the 3 SNPs might be associated with IS, the association varied significantly in different countries. rs2910164 C allele was associated with lower IS risk, but this trend was only observed in Koreans under the allele model, dominant model, recessive model, and homozygous model. rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19–1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23–0.98, p=0.04) only in Chinese. These results suggest that the effect of the SNPs might be significantly related to genetic background of a population.
Some recent studies found some miRNAs are dysregulated in IS. For example, miR-497 can directly bind to the 3′UTR of B-cell lymphoma 2 (Bcl-2) and Bcl-w mRNAs, whose proteins play an important role in attenuating stroke-induced apoptotic cell death [19]. MiR-29b expression was significantly increased in rat brains by focal ischemia. It can also directly bind to the Bcl-2 mRNA and thereby promote neuronal cell death [20]. The miR-146a/rs2910164, miR-196a2/rs11614913, and miR-499/rs3746444 were all in the 3p strand of mature miRNA regions. The G allele of rs2910164 and T allele of rs11614913 are associated with decreased mature miRNA levels [21,22]. This might help to explain why these 2 alleles were associated with increased risk of IS in Koreans and Chinese. In fact, miR-146a can regulate the expression of TNF-α and also inhibit the pro-inflammatory MAP kinase pathway and NF-κB pathway [23], which are closely related to occurrence of IS. A recent study found stroke acutely activates the Toll-like receptor (TLR) signaling pathway in cerebral vasculature. Upregulation of miR-146a contributes to neuroprotection, partly through inactivation of the TLR signaling pathway [24]. MiR-196a2 can regulate annexin A1, which has significant repressing effects on both neutrophil and monocyte migration and adhesion in atherosclerosis. Annexin A1, as an important endogenous anti-inflammatory mediator, can also repress the expression and activation of inflammatory enzymes, such as inducible cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), and phospholipase A2 [25]. Therefore, through regulating annexin A1, miR-196a2 might exert some effect in IS. MiR-499 can regulate CRP, a protein closely related to cerebral ischemia. In addition, mi-499 can also regulate cell apoptosis and cell death in anoxia and ischemia conditions by targeting calcineurin and dynamin-related protein-1 [26]. Since rs3746444 A/G mutation might affect binding of targeting mRNAs and maturation of pre-miRNA, it is possible that this SNP might significantly affect downstream biological functions.
This study also has several limitations. Firstly, due to the limited number of original studies, the number of patients included was relatively small. After a comprehensive literature search, only 5 eligible studies were included. Secondly, the information on clinicopathological characteristics or disease subtypes was poorly provided in original studies, making it difficult to perform more subgroup meta-analysis. Thirdly, IS is a disease influenced by both genetic and environmental factors. The gene-gene and gene-environment interactions may significantly affect function of a single SNP. Therefore, the exact effect of the SNPs may vary in different populations with different genetic backgrounds. In addition, a SNP might be in linkage disequilibrium with other genetic variations of stroke susceptibility genes, which may present stronger effect when considered together with other variations. These hypotheses need to be tested in future studies.
Conclusions
The current meta-analysis suggests that rs2910164 C allele might be associated with lower IS risk in Koreans. rs11614913 T allele might be associated with higher IS risk under the dominant model, while rs3746444 A allele might be associated with decreased IS risk under the homozygous model in Chinese. However, these findings should be further verified in studies with large sample sizes.
References
1. Norrving B, Kissela B, The global burden of stroke and need for a continuum of care: Neurology, 2013; 80; S5-12, pmid: 23319486
2. Domingues-Montanari S, Mendioroz M, del Rio-Espinola A, Genetics of stroke: a review of recent advances: Expert Rev Mol Diagn, 2008; 8(4); 495-513, pmid: 18598230
3. Bersano A, Ballabio E, Bresolin N, Candelise L, Genetic polymorphisms for the study of multifactorial stroke: Hum Mutat, 2008; 29(6); 776-95, pmid: 18421701
4. Ambros V, The functions of animal microRNAs: Nature, 2004; 431; 350-55, pmid: 15372042
5. Jazdzewski K, Murray EL, Franssila K, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma: Proc Natl Acad Sci USA, 2008; 105(20); 7269-74, pmid: 18474871
6. Yang R, Schlehe B, Hemminki K, A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk: Breast Cancer Res Treat, 2010; 121(3); 693-702, pmid: 19921425
7. Ryan BM, Robles AI, Harris CC, Genetic variation in microRNA networks: the implications for cancer research: Nat Rev Cancer, 2010; 10(6); 389-402, pmid: 20495573
8. Park YS, Jeon YJ, Lee BE, Association of the miR-146aC>G, miR-196a2C>T, and miR-499A>G polymorphisms with moyamoya disease in the Korean population: Neurosci Lett, 2012; 521(1); 71-75, pmid: 22659075
9. El Gazzar M, Church A, Liu T, McCall CE, MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming: J Leukoc Biol, 2011; 90(3); 509-19, pmid: 21562054
10. Li SH, Su SY, Liu JL, Differential regulation of microRNAs in patients with ischemic stroke: Curr Neurovasc Res, 2015; 12(3); 214-21, pmid: 26044809
11. Ouyang YB, Xu L, Yue S, Neuroprotection by astrocytes in brain ischemia: importance of microRNAs: Neurosci Lett, 2014; 565; 53-58, pmid: 24269978
12. Luthra R, Singh RR, Luthra MG, MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers: Oncogene, 2008; 27(52); 6667-78, pmid: 18663355
13. Yang B, Chen J, Li Y, Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population: Hum Immunol, 2012; 73(1); 101-6, pmid: 22019503
14. Jeon YJ, Kim OJ, Kim SY, Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk: Arterioscler Thromb Vasc Biol, 2013; 33(2); 420-30, pmid: 23202363
15. Zhu R, Liu X, He Z, Li Q, miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population: Neurochem Res, 2014; 39(9); 1709-16, pmid: 24952884
16. Huang S, Zhou S, Zhang Y, Cheng, Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese population: PLoS One, 2015; 10(2); e0117007, pmid: 25658319
17. Liu Y, Ma Y, Zhang B, Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population: J Mol Neurosci, 2014; 52(4); 473-80, pmid: 24178064
18. Sun J, Association of miR-146a and EPHX2 polymorphisms with risk of ischemic stroke in Changsha Han population and the mechanisms: Master Graduation Thesis, 2011, the Central South University
19. Yadav S, Pandey A, Shukla A, miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2: J Biol Chem, 2011; 286(43); 37347-57, pmid: 21878650
20. Shi G, Liu Y, Liu T, Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury: Exp Brain Res, 2012; 216(2); 225-30, pmid: 22094713
21. Shen J, Ambrosone CB, DiCioccio RA, A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis: Carcinogenesis, 2008; 29(10); 1963-66, pmid: 18660546
22. Hoffman AE, Zheng T, Yi C, microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis: Cancer Res, 2009; 69(14); 5970-77, pmid: 19567675
23. Cheng HS, Sivachandran N, Lau A, MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways: EMBO Mol Med, 2013; 5(7); 949-66, pmid: 23733368
24. Zhang L, Chopp M, Liu X, Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway: Arterioscler Thromb Vasc Biol, 2012; 32(8); 1856-64, pmid: 22723435
25. Perretti M, D’Acquisto F, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation: Nat Rev Immunol, 2009; 9(1); 62-70, pmid: 19104500
26. Wang JX, Jiao JQ, Li Q, miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1: Nat Med, 2011; 17(1); 71-78, pmid: 21186368
In Press
Database Analysis
Neutrophil-to-Lymphocyte Ratio as a Marker for Postoperative Stress in Robot-Assisted Total Knee ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.947906
Clinical Research
Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal PregnanciesMed Sci Monit In Press; DOI: 10.12659/MSM.948358
Clinical Research
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Scle...Med Sci Monit In Press; DOI: 10.12659/MSM.948757
Clinical Research
Cochlear Implantation Benefits for Patients with Trauma-Induced Bilateral Hearing Loss: A Retrospective Ana...Med Sci Monit In Press; DOI: 10.12659/MSM.948554
Most Viewed Current Articles
17 Jan 2024 : Review article 10,151,936
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,515
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 33,887
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 28,286
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- Volume 26, 2020
- More...
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2025
International Scientific Infromation, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2025
International Scientific
Infromation, Inc.
All rights reserved.
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
Your Privacy
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 31, 2025
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- More...
- Volume 26, 2020
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2026
International Scientific Information, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Categories
Archives MSM
- Volume 31, 2025
- Volume 30, 2024
- Volume 29, 2023
- Volume 28, 2022
- Volume 27, 2021
- More...
- Volume 26, 2020
- Volume 25, 2019
- Volume 24, 2018
- Supplement 1
- Volume 23, 2017
- Volume 22, 2016
- Volume 21, 2015
- Volume 20, 2014
- Volume 19, 2013
- Volume 18, 2012
ISI Journals
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Information
Copyright © 2026
International Scientific Information, Inc.
All rights reserved.
About Med Sci Monit

eISSN: 1643-3750
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles Clinical Medicine and related disciplines.
Publisher
International Scientific Information, Inc.
150 Broadhollow Rd., Suite 114
Melville, NY, 11747 | USA
phone:
+1.631.470.9640
e-mail:
[email protected]
www:
www.isi-science.com
Categories
Information
Copyright © 2002 - 2026
International Scientific
Information, Inc.
All rights reserved.






